1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 33
2.5 Porters Fiver Forces Analysis 37
3 Segmentation of North America Market by Drug Type 41
3.1 Market Overview by Drug Type 41
3.2 Immunomodulators 43
3.3 Immunosuppressants 45
4 Segmentation of North America Market by Drug Class 47
4.1 Market Overview by Drug Class 47
4.2 Monoclonal Antibodies 49
4.3 Interferon Beta 50
4.4 Sphingosine 1 Phosphate Receptor Modulators 51
4.5 Mixed Polymers 52
4.6 NF-?B Inhibitor 53
4.7 Pyrimidine Synthesis Inhibitor 54
4.8 Corticosteroids 55
4.9 Adrenocorticotropic Hormone 56
4.10 Other Drug Classes 57
5 Segmentation of North America Market by Drug Category 58
5.1 Market Overview by Drug Category 58
5.2 Large-molecule Drugs 60
5.3 Small-molecule Drugs 61
6 Segmentation of North America Market by Route of Administration 62
6.1 Market Overview by Route of Administration 62
6.2 Oral Administration 64
6.3 Parenteral Administration 65
7 Segmentation of North America Market by MS Type 66
7.1 Market Overview by MS Type 66
7.2 Relapsing-remitting MS (RRMS) 68
7.3 Primary-progressive MS (PPMS) 69
7.4 Secondary-progressive MS (SPMS) 70
7.5 Progressive-relapsing MS (PRMS) 71
8 Segmentation of North America Market by Distribution Channel 72
8.1 Market Overview by Distribution Channel 72
8.2 Hospital Pharmacies 74
8.3 Retail Pharmacies 75
8.4 Online Pharmacies 76
9 North America Market 2020-2027 by Country 77
9.1 Overview of North America Market 77
9.2 U.S. 80
9.3 Canada 83
9.4 Mexico 85
10 Competitive Landscape 87
10.1 Overview of Key Vendors 87
10.2 New Product Launch, Partnership, Investment, and M&A 90
10.3 Company Profiles 91
Abbvie, Inc. 91
Acorda Therapeutics Inc. 93
Bayer AG 94
Biogen Inc. 95
Bristol-Myers Squibb Company 96
F. Hoffmann-La Roche Ltd. 97
Merck KgaA 98
Mylan NV 99
Novartis AG 100
Pfizer Inc. 101
Sanofi SA 102
Teva Pharmaceutical Industries Ltd. 103
RELATED REPORTS 104